Back to search

Poland· PL-100436651

Deslodyna fast junior

A desloratadine product containing desloratadinum, registered in Poland by Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.. The same ATC class is registered in 19 of our 19 countries.

ATC R06AX27

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDeslodyna fast juniorATCR06AX27REGISTER NO.PL-100436651PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Desloratadine is registered in 19 of 19 countries.

Countries holding a registration under ATC R06AX27 (desloratadine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 11 of them publish a price we can compare per daily dose

Desloratadine · ATC R06AX27

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of desloratadine costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.13 in France to $0.51 in Switzerland — a ×3.8 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Desloratadine · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.51
  • IT Italy$0.23
  • FR France$0.13
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Desloratadinum
Manufacturer
Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
Country
Poland (PL)
ATC code
R06AX27
ATC class
Desloratadine
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991486792

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

322 interactions on record for desloratadine.

Graded by severity as the source publishes them — 4 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Desloratadine · interactions on record

322 records

  • 4 moderate
  • 4 minor
  • 314 info

Most severe, free to view

  • Histamine dihydrochlorideL03AX14moderate
  • PitolisantN07XX11moderate
  • TuberculinV04CF01moderate
  • Histamine phosphateV04CG03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Desloratadine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All desloratadine products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Desloraderm, Desloratadin +pharma
  • Belgium · Desloratadin Sandoz, Desloratadine Ab
  • Bulgaria · Дасергин, Десалерган
  • Cyprus · Dareq
  • Czechia · Daslodil, Dasmini
  • Germany · Deslopuren, Deslora
  • Denmark · Desloratadin "glenmark", Desloratadin Gea
  • Estonia · Dasergin, Desloratadine Sopharma
  • Spain · Dasergin, Desloratadina Almus
  • Finland · Caredin, Dasergin
  • France · Desloratadine Almus, Desloratadine Arrow
  • United Kingdom (Northern Ireland) · Desloratadine, Desloratadine Accord Healthcare
  • Greece · Desloratadine Genepharm, Desloratadine Target
  • Croatia · Aerogal, Alerdin
  • Hungary · Dassergo, Desloratadin Teva
  • Ireland · Deslor, Desloratadine Glenmark
  • Iceland · Aerius, Azomyr
  • Italy · Aremas, Desloratadina Aurobindo Italia
  • Liechtenstein · Aerius, Azomyr
  • Lithuania · Dassniz, Desloratadine Sopharma
  • Luxembourg · Desloratadine Eg, Desloratadine Eurogenerics
  • Latvia · Dassniz, Desloratadine Sopharma
  • Malta · Dareq, Deslor
  • Netherlands · Desloratadine Accord, Desloratadine Aurobindo
  • Norway · Aerius, Azomyr
  • Portugal · Bluesar, Clarus
  • Romania · Dasergin, Desloratadina Fiterman
  • Sweden · Caredin, Desloratadin Abece
  • Slovenia · Dasselta Control, Lentrica
  • Slovakia · Daslodil, Dasseltino

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ff9d62bb-22df-4fdc-a6c3-bea9add93e31
GET /v1/drugs/ff9d62bb-22df-4fdc-a6c3-bea9add93e31?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki ulegające rozpadowi w jamie ustnej",
  "source": "urpl",
  "strength": "2,5 mg",
  "packaging": "05909991486792 ¦ OTC ¦ 145516\n10 tabl.",
  "substance": "Desloratadinum 2.5 mg",
  "common_name": "Desloratadinum",
  "pl_product_id": "100436651",
  "pozwolenie_nr": "27149",
  "auth_procedure": "NAR",
  "authorisation_validity": "2027-06-29"
}

See everything about desloratadine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.